Periodic reports (PL)
Announcement date: 31/03/2023 17:09

[ENG] ESPI REPORT RR 2022 – ANNUAL REPORT FOR THE FINANCIAL YEAR 2022 – BRIEF SUMMARY

ANNUAL REPORT OF PURE BIOLOGICS S.A. FOR THE FINANCIAL YEAR 2022 – BRIEF SUMMARY

 

SELECTED FINANCIAL DATA in thousands PLN in thousands PLN in thousands EUR in thousands EUR
2022 2021 2022 2021
SELECTED ITEMS OF THE PROFIT AND LOSS STATEMENT
I. Operating revenues 13 502 18 033 2 880 3 939
II. Total operating expenses 38 297 28 492 8 169 6 224
III. Operating profit (loss) (24 629) (10 482) (5 253) (2 290)
IV. Profit  (loss) before tax (25 603) (11 765) (5 461) (2 570)
V. Net profit (loss) (25 603) (11 765) (5 461) (2 570)
SELECTED ITEMS OF THE CASH FLOW
VI. Net cash flows from operating activities (17 387) (24 035) (3 709) (5 251)
VII. Net cash flows from investment activities 15 345 (28 478) 3 273 (6 221)
VIII. Net cash flows from financial activities (1 876) 49 735 (400) 10 865
IX. Total net cash flows (3 918) (2 778) (836) (607)
SELECTED ITEMS OF THE BALANCE SHEET
X. Total assets/liabilities 33 009 47 190 7 038 10 260
XI. Fixed assets 8 838 4 175 1 884 908
XII. Current assets 24 171 43 015 5 154 9 352
XIII. Equity 18 297 39 486 3 901 8 585
XIV. Liabilities and provisions for liabilities 14 712 7 704 3 137 1 675
XV. Long-term liabilities 1 325 2 155 283 468
XVI. Short-term liabilities 13 387 5 549 2 854 1 206
XVII. Average weighted number of ordinary shares 2 221 123 2 221 123 2 221 123 2 221 123
XVIII. Profit (loss) per ordinary share (in PLN/EUR) (11,53) (5,30) (2,46) (1,16)
XIX. Number of shares at the end of the period 2 254 000 2 254 000 2 254 000 2 254 000
XX. Book value per share (in PLN/EUR) 8,24 17,78 1,76 3,87
 

 

The selected financial figures presented in the report have been converted into euro as follows:
1] Items relating to the statement of profit or loss and other comprehensive income, the cash flow statement and the statement of changes in equity were converted at an exchange rate representing the arithmetic mean of the exchange rates published by the National Bank of Poland on the last day of each month:
– period from 01/01/2022 to 31/12/2022: PLN 4,6883
– period from 01/01/2021 to 31/12/2021: PLN 4,5775
Selected items of the profit and loss statement (I-V) and cash flow statement (VI-IX) presented in thousand PLN and thousand EUR for the financial year ended 31.12.2022 and 31.12.2021.
2] The balance sheet items were converted according to the average exchange rate announced by the National Bank of Poland, in force on the balance sheet date; this exchange rate amounted to:
– As at 31/12/2022: PLN 4,6899
– As at 31/12/2021: PLN 4,5994
Selected items of the balance sheet (X-XX) presented in thousand PLN and thousand EUR as at 31.12.2022 and 31.12.2021.

 

REPORT CONTENT

Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers